NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported an 8 percent increase in fourth quarter revenues, driven by growth across its four business segments.

The company, headquartered in Waltham, Massachusetts, reported Q4 revenues of $6.51 billion, up 8 percent from $6.05 billion in Q4 of 2017 and beating the consensus analyst estimate of $6.23 billion. Organic revenue grew 8 percent, while acquisitions drove revenue up by 1 percent and currency effects decreased revenue by 2 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.